GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Candel Therapeutics, Inc. - Common Stock (CADL)

Symbol: CADL on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$5,523,837	977,512	+49,315	+5.3%	$5.65	Q4 2025
30 Sep 2025	0%	+0%	$4,734,652	928,197	+24,227	+2.7%	$5.10	Q3 2025
30 Jun 2025	0%	+0%	$4,574,865	903,970	+216,509	+31%	$5.06	Q2 2025
31 Mar 2025	0%	+0%	$3,885,208	687,461	+232,037		$5.65	Q1 2025
31 Dec 2024	0%	+0%	$3,953,926	455,424	+6,427	+1.4%	$8.68	Q4 2024
30 Sep 2024	0%	+0%	$3,112,093	448,997	+51,111	+13%	$6.93	Q3 2024
30 Jun 2024	0%	+0%	$2,467,401	397,886	+252,180	+173%	$6.20	Q2 2024
31 Mar 2024	0%	+0%	$230,256	145,706	+6,453	+4.6%	$1.58	Q1 2024
31 Dec 2023	0%	0%	$204,737	139,253	0		$1.47	Q4 2023
30 Sep 2023	0%	+0%	$129,529	139,253	+8,050	+6.1%	$0.93	Q3 2023
30 Jun 2023	0%	0%	$165,315	131,203	0		$1.26	Q2 2023
31 Mar 2023	0%	0%	$179,748	131,203	0		$1.37	Q1 2023
31 Dec 2022	0%	+0%	$234,000	131,203	+2,357	+1.8%	$1.78	Q4 2022
30 Sep 2022	0%	+0%	$404,000	128,846	+53,629	+71%	$3.14	Q3 2022
30 Jun 2022	0%	0%	$243,000	75,217	0		$3.23	Q2 2022
31 Mar 2022	0%	+0%	$382,000	75,217	+16,932	+29%	$5.08	Q1 2022
31 Dec 2021	0%	+0%	$455,000	58,285	+37,890	+186%	$7.81	Q4 2021
30 Sep 2021	0%	+0%	$221,000	20,395	+20,395	NEW	$10.84	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.